Results 291 to 300 of about 48,575 (332)
Some of the next articles are maybe not open access.
Naltrexone and Alzheimer's disease
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1986Naltrexone, an oral opiate antagonist, was administered to nine patients with a diagnosis of Alzheimer's-type dementia (ATD) in a two-phase design: an open dose-ranging phase and a double-blind placebo-controlled trial for patients who showed improvement during the open phase.
Barbara Jordan +5 more
openaire +2 more sources
Rhabdomyolysis Associated with Naltrexone
Annals of Pharmacotherapy, 1999OBJECTIVE: To report a possible association between naltrexone therapy and the development of rhabdomyolysis in one patient. CASE SUMMARY: A 28-year-old white man in good physical health was started on naltrexone 50 mg/d for inpatient treatment of alcohol dependence and depression. A routine serum chemistry panel obtained on day 9 of naltrexone therapy
Sina Zaim +2 more
openaire +3 more sources
Pregnancy and Naltrexone Pharmacotherapy
Obstetrics & Gynecology, 2018A 25-year-old woman, gravida 3 para 2 at 12 weeks of gestation, with two prior cesarean deliveries, presents for prenatal care. She is in treatment for opioid use disorder on extended-release naltrexone injection, with a history of opioid overdose, relapse, and poor treatment adherence on methadone and buprenorphine.
Cresta W. Jones, Mishka Terplan
openaire +2 more sources
Blood naltrexone levels over time following naltrexone implant
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2008Oral naltrexone is used in the management of both heroin and alcohol dependence. However, poor compliance has limited its clinical utility. The study's objective was to determine the period of therapeutic coverage (>or=2 ng/ml) provided by a 3.3 g naltrexone subcutaneous implant compared with existing data on 1.1 g and 2.2 g implants.We assessed free ...
Ngo, Hanh +4 more
openaire +3 more sources
Naltrexone influence on hibernation
Experientia, 1980In the garden dormouse, opiate receptor blockade by naltrexone decreased the score for sleeping behaviour during hibernation at 24.00 h, indicative of a possible involvement of endorphins in the control of hibernation.
W. Kromer, W. Kromer
openaire +3 more sources
JAMA dermatology, 2019
Importance Dermatology is encountering increasing rates of autoimmune disease manifesting in primary skin conditions that are difficult to treat without a risk of immunosuppression.
C. Ekelem +3 more
semanticscholar +1 more source
Importance Dermatology is encountering increasing rates of autoimmune disease manifesting in primary skin conditions that are difficult to treat without a risk of immunosuppression.
C. Ekelem +3 more
semanticscholar +1 more source
Naltrexone for probationers and parolees
Journal of Substance Abuse Treatment, 2006Heroin addiction is a chronic disorder that is usually associated with crimes aimed to obtain funds for the purchase of this illegal drug. When these addicted individuals are apprehended and incarcerated, they temporarily obtain drug-free status, but relapse quickly upon release.
James W. Cornish, Charles A. O'Brien
openaire +2 more sources
Addiction Biology, 2004
AbstractThe aim of this study was to profile and compare blood naltrexone and 6‐ β‐ naltrexol levels with time following treatment with two sustained‐release naltrexone preparations produced by GoMedical Industries, Australia at a community heroin treatment clinic in Perth, Western Australia. A sample of 10 patients who each received a 1.7 g naltrexone
Hulse, Gary K +5 more
openaire +4 more sources
AbstractThe aim of this study was to profile and compare blood naltrexone and 6‐ β‐ naltrexol levels with time following treatment with two sustained‐release naltrexone preparations produced by GoMedical Industries, Australia at a community heroin treatment clinic in Perth, Western Australia. A sample of 10 patients who each received a 1.7 g naltrexone
Hulse, Gary K +5 more
openaire +4 more sources
Chest, 1988
The narcotic antagonists naloxone and naltrexone were used as respiratory stimulants in two patients failing traditional medical therapy for COPD. Both patients demonstrated improvement while receiving the drugs, but developed respiratory failure when they were discontinued abruptly.
Stan B. Reents, Charles A. Beck
openaire +3 more sources
The narcotic antagonists naloxone and naltrexone were used as respiratory stimulants in two patients failing traditional medical therapy for COPD. Both patients demonstrated improvement while receiving the drugs, but developed respiratory failure when they were discontinued abruptly.
Stan B. Reents, Charles A. Beck
openaire +3 more sources
NALTREXONE IN THE TREATMENT OF ALCOHOLISM
Annual Review of Medicine, 1997▪ Abstract Alcoholism affects nearly 12.5 million Americans and is responsible for annual costs of over $130 billion from loss of job productivity, deleterious health effects, and direct treatment expenses. Research on treating alcoholism from the standpoint of relapse prevention using psychosocial interventions alone has produced only modest results.
Weinrieb Rm, Charles P. O'Brien
openaire +3 more sources